| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. | N Engl J Med | 2013 | 18.08 |
| 2 | The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study. | J Card Fail | 2010 | 0.81 |